tiprankstipranks
Amneal Pharma and the AI Dilemma: Balancing Innovation with Emerging Risks and Regulations
PremiumCompany AnnouncementsAmneal Pharma and the AI Dilemma: Balancing Innovation with Emerging Risks and Regulations
1M ago
Amneal Pharmaceuticals (NASDAQ:AMRX) Presents a Compelling Option for Value Investors
PremiumMarket News
Amneal Pharmaceuticals (NASDAQ:AMRX) Presents a Compelling Option for Value Investors
1M ago
Amneal Pharmaceuticals management to meet with Piper Sandler
PremiumThe Fly
Amneal Pharmaceuticals management to meet with Piper Sandler
1M ago
Is AMRX a Buy, Before Earnings?
PremiumPre-EarningsIs AMRX a Buy, Before Earnings?
2M ago
Amneal in licensing agreement with Zambon Biotech for IPX203
PremiumThe Fly
Amneal in licensing agreement with Zambon Biotech for IPX203
2M ago
Amneal provides complete response resubmission to FDA  for IPX203 NDA
PremiumThe Fly
Amneal provides complete response resubmission to FDA for IPX203 NDA
2M ago
Amneal Pharmaceuticals announces Ongentys licensing agreement
PremiumThe FlyAmneal Pharmaceuticals announces Ongentys licensing agreement
4M ago
Amneal Pharmaceuticals price target raised to $6 from $5 at Barclays
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $6 from $5 at Barclays
5M ago
Amneal Pharmaceuticals raises 2023 adjusted EPS view to 51c-58c from 45c-55c
PremiumThe Fly
Amneal Pharmaceuticals raises 2023 adjusted EPS view to 51c-58c from 45c-55c
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100